Fracture risk is increased in epilepsy

Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical follow‐up. Self‐administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to (340.9) and 1000 randomly selected controls f...

Full description

Saved in:
Bibliographic Details
Published inActa neurologica Scandinavica Vol. 99; no. 5; pp. 269 - 275
Main Authors Vestergaard, P., Tigaran, S., Rejnmark, L., Tigaran, C., Dam, M., Mosekilde, L.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.05.1999
Blackwell
Subjects
Online AccessGet full text
ISSN0001-6314
1600-0404
DOI10.1111/j.1600-0404.1999.tb00675.x

Cover

Abstract Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical follow‐up. Self‐administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to (340.9) and 1000 randomly selected controls from the background population. Results ‐ A total of 345 patients (median age: 45, range 17–80 years) and 654 control subjects (median age: 43. range 19–93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8–1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6–2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3–43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0–1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1–5.4) and a family fracture history (OR = 2.4, 95% CI: 1.34.6) was associated with an increased fracture risk. Conclusions ‐ Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence.
AbstractList To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy. Historical follow-up. Self-administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to G40.9) and 1000 randomly selected controls from the background population. A total of 345 patients (median age: 45, range 17-80 years) and 654 control subjects (median age: 43, range 19-93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8-1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6-2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3-43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0-1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1-5.4) and a family fracture history (OR = 2.4, 95% CI: 1.3-4.6) was associated with an increased fracture risk. Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence.
Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical follow‐up. Self‐administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to (340.9) and 1000 randomly selected controls from the background population. Results ‐ A total of 345 patients (median age: 45, range 17–80 years) and 654 control subjects (median age: 43. range 19–93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8–1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6–2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3–43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0–1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1–5.4) and a family fracture history (OR = 2.4, 95% CI: 1.34.6) was associated with an increased fracture risk. Conclusions ‐ Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence.
To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy.OBJECTIVESTo study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy.Historical follow-up. Self-administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to G40.9) and 1000 randomly selected controls from the background population.MATERIAL AND METHODSHistorical follow-up. Self-administered questionnaires were issued to 755 patients with epilepsy (ICD 10: G40.0 to G40.9) and 1000 randomly selected controls from the background population.A total of 345 patients (median age: 45, range 17-80 years) and 654 control subjects (median age: 43, range 19-93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8-1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6-2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3-43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0-1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1-5.4) and a family fracture history (OR = 2.4, 95% CI: 1.3-4.6) was associated with an increased fracture risk.RESULTSA total of 345 patients (median age: 45, range 17-80 years) and 654 control subjects (median age: 43, range 19-93 years) returned the questionnaire. Before epilepsy was diagnosed there was no difference in overall fracture rate between patients and controls (RR = 1.0, 95% CI: 0.8-1.3). After the diagnosis the overall fracture rate was significantly higher in the patients (RR = 2.0, 95% CI: 1.6-2.5). Fractures of the spine, forearms, femurs, lower legs, and feet and toes were significantly increased. Fractures related to seizures accounted for 33.9% (95% CI: 25.3-43.5%) of all fractures. After elimination of seizure related fractures the increase in fracture frequency was only borderline significant: RR = 1.3 (95% CI: 1.0-1.7, P = 0.042). No difference in fracture energy between patients and controls was observed (low energy fractures: 1.7/1.4%, medium energy fractures: 59.8/52.0%, and high energy fractures: 38.3/46.6%). Use of phenytoin (OR = 2.4, 95% CI: 1.1-5.4) and a family fracture history (OR = 2.4, 95% CI: 1.3-4.6) was associated with an increased fracture risk.Fractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence.CONCLUSIONSFractures were more common in epileptics than in controls especially among users of phenytoin. Most of the increase in fracture frequency was related to seizures and not to low bone biomechanical competence.
Author Vestergaard, P.
Tigaran, S.
Tigaran, C.
Rejnmark, L.
Mosekilde, L.
Dam, M.
Author_xml – sequence: 1
  givenname: P.
  surname: Vestergaard
  fullname: Vestergaard, P.
– sequence: 2
  givenname: S.
  surname: Tigaran
  fullname: Tigaran, S.
– sequence: 3
  givenname: L.
  surname: Rejnmark
  fullname: Rejnmark, L.
– sequence: 4
  givenname: C.
  surname: Tigaran
  fullname: Tigaran, C.
– sequence: 5
  givenname: M.
  surname: Dam
  fullname: Dam, M.
– sequence: 6
  givenname: L.
  surname: Mosekilde
  fullname: Mosekilde, L.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1775106$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10348155$$D View this record in MEDLINE/PubMed
BookMark eNqVkFtLwzAYhoNM3EH_ggwR71qTNYfGC3GMTYWhN3od0vQrZHbtTDrc_r2pmw680twkIc_38ubpo05VV4DQBcExCet6EROOcYQppjGRUsZNhjEXLN4cod7PUwf1MMYk4gmhXdT3fhFuI0HpCeoSnNCUMNZDVzOnTbN2MHTWvw2tH9rKONAe8nAawsqWsPLbU3Rc6NLD2X4foNfZ9GXyEM2f7x8n43lkklAkApIBEVnKZSK1kawQoxyKnBY8TzFLGB0JIyTVUuZMCK5T4CmDrEih4JrleTIIhb5yV65-X4Nv1NJ6A2WpK6jXXnEpUk4TEcDzPbjOlpCrlbNL7bbq-2cBuNwD2htdFk5XxvoDJwQjmAfsbocZV3vvoFDGNrqxddU4bcuQp1rnaqFasaoVq1rnau9cbULEza-IQ5k_DN_uhj-C6O0_JtX4aToKnj8Bt8-ZKA
CODEN ANRSAS
CitedBy_id crossref_primary_10_1016_j_yebeh_2003_11_030
crossref_primary_10_1016_j_rbo_2017_01_012
crossref_primary_10_1111_epi_12351
crossref_primary_10_1016_j_bone_2023_116784
crossref_primary_10_1016_j_eplepsyres_2012_09_002
crossref_primary_10_1097_01_nrl_0000087719_64343_be
crossref_primary_10_1016_j_rhum_2007_01_024
crossref_primary_10_5937_mp75_51140
crossref_primary_10_1016_j_bbapap_2010_05_014
crossref_primary_10_1016_j_drudis_2009_01_004
crossref_primary_10_1111_epi_16678
crossref_primary_10_1016_j_yebeh_2013_12_021
crossref_primary_10_1186_s41983_018_0014_2
crossref_primary_10_1186_s13018_020_02151_1
crossref_primary_10_1016_j_jclinepi_2011_09_004
crossref_primary_10_1203_PDR_0b013e31820bc6d3
crossref_primary_10_1046_j_1528_1157_2002_15801_x
crossref_primary_10_1590_S0004_282X2004000600003
crossref_primary_10_1007_s00402_022_04420_6
crossref_primary_10_1517_14740338_2011_534455
crossref_primary_10_1111_j_1528_1167_2009_02170_x
crossref_primary_10_1007_s13670_014_0078_5
crossref_primary_10_1007_s00198_008_0711_2
crossref_primary_10_1016_j_clineuro_2007_07_002
crossref_primary_10_1212_01_WNL_0000142991_14507_B5
crossref_primary_10_1046_j_1528_1157_2002_18701_x
crossref_primary_10_1016_j_yebeh_2019_106651
crossref_primary_10_1111_epi_16700
crossref_primary_10_1186_1471_2431_13_211
crossref_primary_10_1007_s10049_020_00784_7
crossref_primary_10_1212_WNL_63_10_suppl_4_S24
crossref_primary_10_1111_j_0013_9580_2005_23804_x
crossref_primary_10_1093_ageing_afs178
crossref_primary_10_4061_2010_808341
crossref_primary_10_1016_j_yebeh_2004_02_005
crossref_primary_10_1016_j_jbspin_2019_11_003
crossref_primary_10_1016_j_arth_2022_08_022
crossref_primary_10_1046_j_1535_7597_2003_03306_x
crossref_primary_10_1111_j_0013_9580_2004_18804_x
crossref_primary_10_1186_1743_7075_3_36
crossref_primary_10_1177_1759720X13475851
crossref_primary_10_1111_j_1528_1167_2006_00666_x
crossref_primary_10_1007_s00115_004_1803_7
crossref_primary_10_1016_S0090_3019_02_00837_6
crossref_primary_10_2165_00002018_200730020_00006
crossref_primary_10_1212_01_WNL_0000125185_74276_D2
crossref_primary_10_5694_j_1326_5377_2005_tb07001_x
crossref_primary_10_17749_2077_8333_epi_par_con_2022_117
crossref_primary_10_1007_s11910_013_0361_4
crossref_primary_10_1111_j_0013_9580_2004_33803_x
crossref_primary_10_1016_j_yebeh_2019_106511
crossref_primary_10_1007_s10309_005_0141_5
crossref_primary_10_1016_j_yebeh_2006_08_003
crossref_primary_10_1016_j_seizure_2020_10_003
crossref_primary_10_1016_j_eplepsyres_2004_05_004
crossref_primary_10_1111_j_1528_1167_2007_01499_x
crossref_primary_10_1111_j_1600_0404_2005_00474_x
crossref_primary_10_1517_14740338_6_3_251
crossref_primary_10_1093_jamia_ocv061
crossref_primary_10_1007_s00774_023_01475_2
crossref_primary_10_1530_EJE_15_0118
crossref_primary_10_1016_j_jse_2023_09_023
crossref_primary_10_1161_circ_102_suppl_1_I_77
crossref_primary_10_1016_j_neuchi_2021_04_004
crossref_primary_10_1186_s13690_020_00405_2
crossref_primary_10_1016_S8756_3282_02_00788_3
crossref_primary_10_3389_fneur_2014_00142
crossref_primary_10_4065_82_1_40
crossref_primary_10_1016_j_jbspin_2007_01_039
crossref_primary_10_1007_s11940_008_0026_9
crossref_primary_10_1186_1757_1626_3_30
crossref_primary_10_1016_j_annemergmed_2005_03_009
crossref_primary_10_1016_j_rboe_2017_03_009
crossref_primary_10_1007_s11910_004_0060_2
crossref_primary_10_1016_j_monrhu_2011_01_002
crossref_primary_10_1007_s00198_013_2446_y
crossref_primary_10_1016_j_eplepsyres_2005_07_016
crossref_primary_10_1016_j_jns_2013_05_005
crossref_primary_10_1359_jbmr_2003_18_5_900
crossref_primary_10_1007_s11914_016_0302_7
crossref_primary_10_1111_epi_14738
crossref_primary_10_1016_j_seizure_2012_10_002
crossref_primary_10_1212_WNL_61_6_suppl_2_S16
crossref_primary_10_1080_14740338_2018_1524868
crossref_primary_10_1016_j_rhum_2020_01_035
crossref_primary_10_1111_epi_16465
crossref_primary_10_1111_j_1528_1167_2008_01640_x
crossref_primary_10_4065_76_2_175
crossref_primary_10_1007_s00125_005_1786_3
crossref_primary_10_1212_01_CON_0000368237_49610_93
crossref_primary_10_1016_j_spen_2017_10_005
crossref_primary_10_1111_j_1528_1167_2006_00803_x
crossref_primary_10_1007_s11940_015_0342_9
crossref_primary_10_1590_S1676_26492010000200007
crossref_primary_10_1007_s11282_023_00671_0
crossref_primary_10_1007_s00198_006_0185_z
crossref_primary_10_1016_j_bone_2014_04_018
crossref_primary_10_1016_S0025_6196_11_63125_X
crossref_primary_10_1002_epi4_12776
crossref_primary_10_1016_j_amjopharm_2010_02_003
crossref_primary_10_1016_S1474_4422_04_00935_4
crossref_primary_10_1007_s43440_020_00087_1
crossref_primary_10_1016_S0300_9572_00_00273_2
crossref_primary_10_1111_j_1365_2796_2005_01467_x
crossref_primary_10_1007_s00223_012_9603_8
crossref_primary_10_1016_j_ijep_2017_04_001
crossref_primary_10_1155_2015_646352
crossref_primary_10_1007_s00198_005_1892_6
crossref_primary_10_3389_fpsyt_2023_1208887
crossref_primary_10_1016_j_spen_2007_08_006
crossref_primary_10_1177_1759720X14546350
crossref_primary_10_1016_S0920_1211_00_00126_1
crossref_primary_10_1016_j_clineuro_2011_03_011
crossref_primary_10_1542_peds_2013_2554
crossref_primary_10_1016_j_eplepsyres_2020_106461
crossref_primary_10_1016_j_jamda_2022_06_001
crossref_primary_10_2217_ahe_09_88
crossref_primary_10_2165_00023210_200115080_00006
crossref_primary_10_1016_S0025_6196_11_60965_8
crossref_primary_10_1111_j_1532_5415_2007_01081_x
crossref_primary_10_1080_09674845_2019_1663781
crossref_primary_10_1016_j_pjnns_2015_06_007
crossref_primary_10_1016_S1525_5050_03_00036_2
crossref_primary_10_1111_j_1528_1167_2009_02254_x
crossref_primary_10_2217_14750708_4_1_79
crossref_primary_10_1016_j_berh_2022_101755
crossref_primary_10_1586_14737175_9_2_291
crossref_primary_10_1111_j_0013_9580_2004_33903_x
crossref_primary_10_1212_WNL_0000000000003629
crossref_primary_10_1007_s00223_008_9124_7
crossref_primary_10_1210_jc_2013_4275
crossref_primary_10_1016_j_yebeh_2003_11_027
crossref_primary_10_1016_j_yebeh_2003_11_026
crossref_primary_10_1136_bcr_2019_230143
crossref_primary_10_1016_j_yebeh_2003_11_029
crossref_primary_10_1016_j_yebeh_2003_11_028
crossref_primary_10_55095_achot2007_032
crossref_primary_10_2522_ptj_20100383
crossref_primary_10_1007_s11926_008_0019_4
Cites_doi 10.1111/j.1528-1157.1993.tb02099.x
10.1016/0221-8747(80)90001-6
10.1001/archneur.1996.00550090141020
10.1056/NEJM199503233321202
10.1016/1047-2797(94)00100-8
10.1111/j.1528-1157.1997.tb01733.x
10.1016/0020-1383(95)00189-1
10.1056/NEJM199212033272305
10.1111/j.0954-6820.1979.tb06073.x
10.1111/j.1528-1157.1995.tb01660.x
10.1038/sj.sc.3100648
10.3109/17453677708992008
10.1172/JCI109142
10.1007/BF00433931
10.1016/0735-6757(95)90213-9
10.1002/jbmr.5650110920
10.1111/j.0954-6820.1979.tb06072.x
10.7326/0003-4819-77-3-389
ContentType Journal Article
Copyright 1999 Blackwell Munksgaard
1999 INIST-CNRS
Copyright_xml – notice: 1999 Blackwell Munksgaard
– notice: 1999 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1600-0404.1999.tb00675.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0404
EndPage 275
ExternalDocumentID 10348155
1775106
10_1111_j_1600_0404_1999_tb00675_x
ANE269
Genre caseStudy
Clinical Trial
Randomized Controlled Trial
Journal Article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJEY
AAKAS
AANHP
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABJNI
ABLJU
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCMX
ACCZN
ACGFS
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFFNX
AFGKR
AFKRA
AFPWT
AFZJQ
AHEFC
AHMBA
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPS
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
FYUFA
FZ0
G-S
G.N
GODZA
H.X
H13
HF~
HMCUK
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PIMPY
PQQKQ
Q.N
Q11
QB0
R.K
RHX
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7X8
ID FETCH-LOGICAL-c3999-e1be17b86939ac95f72defd4f6d80535427c794a99d5776a8e685ebf8ef6a5dd3
IEDL.DBID DR2
ISSN 0001-6314
IngestDate Fri Sep 05 06:38:40 EDT 2025
Wed Feb 19 02:32:33 EST 2025
Mon Jul 21 09:13:49 EDT 2025
Tue Jul 01 00:38:46 EDT 2025
Thu Apr 24 23:02:26 EDT 2025
Wed Jan 22 17:07:27 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Nervous system diseases
Epilepsy
Diseases of the osteoarticular system
Anticonvulsant
Fracture
Trauma
Cerebral disorder
Chemotherapy
Type
Central nervous system disease
Risk factor
Adult
Complication
Frequency
Bone
Language English
License http://doi.wiley.com/10.1002/tdm_license_1.1
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3999-e1be17b86939ac95f72defd4f6d80535427c794a99d5776a8e685ebf8ef6a5dd3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
PMID 10348155
PQID 69786437
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_69786437
pubmed_primary_10348155
pascalfrancis_primary_1775106
crossref_citationtrail_10_1111_j_1600_0404_1999_tb00675_x
crossref_primary_10_1111_j_1600_0404_1999_tb00675_x
wiley_primary_10_1111_j_1600_0404_1999_tb00675_x_ANE269
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate May 1999
PublicationDateYYYYMMDD 1999-05-01
PublicationDate_xml – month: 05
  year: 1999
  text: May 1999
PublicationDecade 1990
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: Denmark
PublicationTitle Acta neurologica Scandinavica
PublicationTitleAlternate Acta Neurol Scand
PublicationYear 1999
Publisher Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
References 1993; 34
1986; 105
1977; 48
1995; 36
1997; 52
1980; 2
1995; 13
1979; 205
1978; 62
1992; 327
1997; 38
1994
1995; 332
1996; 27
1972; 77
1995; 5
1996; 53
1998; 36
1996; 11
Lidgren (10.1111/j.1600-0404.1999.tb00675.x-BIB1) 1977; 48
Sotaniemi (10.1111/j.1600-0404.1999.tb00675.x-BIB14) 1972; 77
Kirby (10.1111/j.1600-0404.1999.tb00675.x-BIB7) 1995; 36
Wirrell (10.1111/j.1600-0404.1999.tb00675.x-BIB8) 1996; 53
Chapuy (10.1111/j.1600-0404.1999.tb00675.x-BIB16) 1992; 327
Seeley (10.1111/j.1600-0404.1999.tb00675.x-BIB5) 1996; 11
Buck (10.1111/j.1600-0404.1999.tb00675.x-BIB6) 1997; 38
Vestercaard (10.1111/j.1600-0404.1999.tb00675.x-BIB19) 1998; 36
Jaclal (10.1111/j.1600-0404.1999.tb00675.x-BIB4) 1995; 5
Dymlinc (10.1111/j.1600-0404.1999.tb00675.x-BIB11) 1979; 205
Cummings (10.1111/j.1600-0404.1999.tb00675.x-BIB3) 1995; 332
Mosekilde (10.1111/j.1600-0404.1999.tb00675.x-BIB10) 1979; 205
Mosekilde (10.1111/j.1600-0404.1999.tb00675.x-BIB13) 1980; 2
10.1111/j.1600-0404.1999.tb00675.x-BIB15
Hahn (10.1111/j.1600-0404.1999.tb00675.x-BIB18) 1978; 62
Nilsson (10.1111/j.1600-0404.1999.tb00675.x-BIB12) 1986; 105
Desai (10.1111/j.1600-0404.1999.tb00675.x-BIB2) 1996; 27
Cohen (10.1111/j.1600-0404.1999.tb00675.x-BIB17) 1997; 52
Elbercer (10.1111/j.1600-0404.1999.tb00675.x-BIB20) 1995; 13
Nakken (10.1111/j.1600-0404.1999.tb00675.x-BIB9) 1993; 34
References_xml – volume: 36
  start-page: 25
  year: 1995
  end-page: 8
  article-title: Injury and death as a result of seizures
  publication-title: Epilepsia
– volume: 205
  start-page: 405
  year: 1979
  end-page: 9
  article-title: Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy: short term effects of 1,25‐dihydroxycholecal‐ciferol and 25‐hydroxycholecalciferol
  publication-title: Acta Med Scand
– volume: 27
  start-page: 97
  year: 1996
  end-page: 100
  article-title: Incidence of five common fracture types in an institutional epileptic population
  publication-title: Injury
– volume: 11
  start-page: 1347
  year: 1996
  end-page: 55
  article-title: Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group
  publication-title: J Bone Miner Res
– volume: 77
  start-page: 389
  year: 1972
  end-page: 94
  article-title: Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy
  publication-title: Ann Intern Med
– volume: 13
  start-page: 331
  year: 1995
  end-page: 2
  article-title: Bilateral posterior shoulder dislocations
  publication-title: Am J Emerg Med
– volume: 34
  start-page: 836
  year: 1993
  end-page: 40
  article-title: Seizure‐related injuries in multi‐handicapped patients with therapy‐resistant epilepsy
  publication-title: Epilepsia
– volume: 38
  start-page: 439
  year: 1997
  end-page: 44
  article-title: Patients' experiences of injury as a result of epilepsy
  publication-title: Epilepsia
– volume: 36
  start-page: 790
  year: 1998
  end-page: 6
  article-title: Fracture rates and risk factors for fractures in patients with spinal cord injury
  publication-title: Spinal Cord
– volume: 332
  start-page: 767
  year: 1995
  end-page: 73
  article-title: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
  publication-title: N Engl J Med
– volume: 62
  start-page: 406
  year: 1978
  end-page: 14
  article-title: Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal medication of fetal rat bone resorption in vitro
  publication-title: J Clin Invest
– volume: 48
  start-page: 356
  year: 1977
  end-page: 61
  article-title: Incidence of fracture in epileptics
  publication-title: Acta Orthop Scand
– volume: 2
  start-page: 77
  year: 1980
  end-page: 82
  article-title: Dynamic differences in trabecular bone remodeling between patients after jejunoileal bypass for obesity and epileptic patients receiving anticonvulsant therapy
  publication-title: Metab Bone Dis & Rel Res
– volume: 52
  start-page: 70,75
  year: 1997
  end-page: 8,81
  article-title: Strategies to protect bone mass in the older patient with epilepsy
  publication-title: Geriatrics
– volume: 205
  start-page: 401
  year: 1979
  end-page: 4
  article-title: Biochemical variables related to calcium metabolism in epileptics
  publication-title: Acta Med Scand
– volume: 53
  start-page: 929
  year: 1996
  end-page: 32
  article-title: Accidental injury is a serious risk in children with typical absence epilepsy
  publication-title: Arch Neurol
– volume: 327
  start-page: 1637
  year: 1992
  end-page: 42
  article-title: Vitamin D, and calcium to prevent hip fractures in elderly women
  publication-title: N Engl J Med
– volume: 5
  start-page: 321
  year: 1995
  end-page: 4
  article-title: Lifetime occupational physical activity and risk of hip fracture in women
  publication-title: Ann Epidemiol
– volume: 105
  start-page: 146
  year: 1986
  end-page: 9
  article-title: Fracture incidence and bone disease in epileptics receiving long‐term anticonvulsant drug treatment
  publication-title: Arch Orthop Trauma Surg
– year: 1994
– volume: 34
  start-page: 836
  year: 1993
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB9
  article-title: Seizure-related injuries in multi-handicapped patients with therapy-resistant epilepsy
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.1993.tb02099.x
– volume: 2
  start-page: 77
  year: 1980
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB13
  article-title: Dynamic differences in trabecular bone remodeling between patients after jejunoileal bypass for obesity and epileptic patients receiving anticonvulsant therapy
  publication-title: Metab Bone Dis & Rel Res
  doi: 10.1016/0221-8747(80)90001-6
– volume: 53
  start-page: 929
  year: 1996
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB8
  article-title: Accidental injury is a serious risk in children with typical absence epilepsy
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1996.00550090141020
– volume: 332
  start-page: 767
  year: 1995
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB3
  article-title: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199503233321202
– volume: 5
  start-page: 321
  year: 1995
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB4
  article-title: Lifetime occupational physical activity and risk of hip fracture in women
  publication-title: Ann Epidemiol
  doi: 10.1016/1047-2797(94)00100-8
– volume: 38
  start-page: 439
  year: 1997
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB6
  article-title: Patients' experiences of injury as a result of epilepsy
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.1997.tb01733.x
– ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB15
– volume: 27
  start-page: 97
  year: 1996
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB2
  article-title: Incidence of five common fracture types in an institutional epileptic population
  publication-title: Injury
  doi: 10.1016/0020-1383(95)00189-1
– volume: 327
  start-page: 1637
  year: 1992
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB16
  article-title: Vitamin D, and calcium to prevent hip fractures in elderly women
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199212033272305
– volume: 205
  start-page: 405
  year: 1979
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB10
  article-title: Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy: short term effects of 1,25-dihydroxycholecal-ciferol and 25-hydroxycholecalciferol
  publication-title: Acta Med Scand
  doi: 10.1111/j.0954-6820.1979.tb06073.x
– volume: 36
  start-page: 25
  year: 1995
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB7
  article-title: Injury and death as a result of seizures
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.1995.tb01660.x
– volume: 52
  start-page: 70,75
  year: 1997
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB17
  article-title: Strategies to protect bone mass in the older patient with epilepsy
  publication-title: Geriatrics
– volume: 36
  start-page: 790
  year: 1998
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB19
  article-title: Fracture rates and risk factors for fractures in patients with spinal cord injury
  publication-title: Spinal Cord
  doi: 10.1038/sj.sc.3100648
– volume: 48
  start-page: 356
  year: 1977
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB1
  article-title: Incidence of fracture in epileptics
  publication-title: Acta Orthop Scand
  doi: 10.3109/17453677708992008
– volume: 62
  start-page: 406
  year: 1978
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB18
  article-title: Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal medication of fetal rat bone resorption in vitro
  publication-title: J Clin Invest
  doi: 10.1172/JCI109142
– volume: 105
  start-page: 146
  year: 1986
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB12
  article-title: Fracture incidence and bone disease in epileptics receiving long-term anticonvulsant drug treatment
  publication-title: Arch Orthop Trauma Surg
  doi: 10.1007/BF00433931
– volume: 13
  start-page: 331
  year: 1995
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB20
  article-title: Bilateral posterior shoulder dislocations
  publication-title: Am J Emerg Med
  doi: 10.1016/0735-6757(95)90213-9
– volume: 11
  start-page: 1347
  year: 1996
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB5
  article-title: Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.5650110920
– volume: 205
  start-page: 401
  year: 1979
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB11
  article-title: Biochemical variables related to calcium metabolism in epileptics
  publication-title: Acta Med Scand
  doi: 10.1111/j.0954-6820.1979.tb06072.x
– volume: 77
  start-page: 389
  year: 1972
  ident: 10.1111/j.1600-0404.1999.tb00675.x-BIB14
  article-title: Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-77-3-389
SSID ssj0012744
Score 1.9534687
Snippet Objectives ‐ To study fracture rates and risk factors for fractures in non‐institutionalized patients with epilepsy. Material and methods ‐ Historical...
To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy. Historical follow-up. Self-administered questionnaires...
To study fracture rates and risk factors for fractures in non-institutionalized patients with epilepsy.OBJECTIVESTo study fracture rates and risk factors for...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 269
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Anticonvulsants - therapeutic use
Biological and medical sciences
Biomechanical Phenomena
epilepsy
Epilepsy - complications
Epilepsy - drug therapy
Female
fracture
Fractures, Bone - epidemiology
Fractures, Bone - etiology
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Incidence
Male
Medical sciences
Middle Aged
Nervous system (semeiology, syndromes)
Neurology
Phenytoin - therapeutic use
phenytoin. risk
Risk Factors
seizures
Title Fracture risk is increased in epilepsy
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0404.1999.tb00675.x
https://www.ncbi.nlm.nih.gov/pubmed/10348155
https://www.proquest.com/docview/69786437
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5CDiVQ-n44aVofSm9eVtb7GJIsodAcQgK5CT3GENo6S7wLbX59NLZ3my0ttKU3X8ayRvqkb6yZTwDvUWY0M5MqbJipBAu6sobnwDXEWkZPYjq92uepOrkQHy_l5VgeTbUwgz7E-ocbIaNfrwngPnSbIFdUFS2mgkrubP-PM9PfCTFKxhUJ6R-drbWkGEnhDVyYVYozMSqQjmk9v3nVxm71cO677LhmuPHiV5R0k-H2W9TsMXxddW7ITPk8WS7CJN7-pPv4v3r_BB6NXLY8GCbfU9jC9hk8-DSe1j-HDzMqwVreYEkJ7OVVV161RFI7TPmpxHlued59fwEXs-Pzw5NqvJehipxEC5AFZDoYZbn10cpG1wmbJBqVDMnFiFrHDHNvbZJaK29QGYmhMdgoL1PiL2G7vW7xNZRTraLmKYdpiosk8_oSMSUjQkSv47QuwK787-IoWk53Z3xx94KX7AhHjnDkCDc6wn0rgK9t54N0xx9Z7W8M8w9TrfP6pQp4txp2l5FIxyu-xetl51QOyOkYtIBXw2y41yqVO0tZgO7H9C8-xx2cHtfK7v6z5R7sDEoTlKP5BrYXN0vczzxqEd72-LgDGh8Mrg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED8hJg0ktPE1yDYgD4i3VE3iz0e0UZVB-4BA4s1K7ItUMYWKtBLw18-XpIWiIY2Jt7xcbN_57N_Zdz8DHCL33hwrF2ERq4jFuYy0Sn3gmtuE24zIdGq2z6HoX7Ff1_x6CQazWpiGH2J-4EaeUa_X5OB0IL3o5YLKolmXUc2drg85Pf7teEj5gXnkQbHYz4s5m1RMZHgNGo4jkcas5SBtE3te-dfCfrU2ziqvuqJ58-JvoHQR49abVO8zlLPhNbkpN53pJO_YxxfMj-82_nX41MLZ8LiZfxuwhOUmfBy0F_ZbcNSjKqzpHYaUwx6OqnBUEk6t0PmvEMe-6XH1sA1XvZPLH_2ofZohsinxFmCcYyxzJXSqM6t5IROHhWOFcIoYY1girff0TGvHpRSZQqE45oXCQmTcufQLLJe3Je5C2JXCytT5SE2kzHG_xFh0TrHcYiZtNwlAzwxgbMtbTs9n_DbP4hevCEOKMKQI0yrC3AeQzmXHDXvHP0ntLdj5SVRKv4SJAA5mdjfeGemGJSvxdloZ4WNyugkNYKeZDs9apYpnzgOQtVHf0B1zPDxJhP7635IHsNK_HJyb89Ph2TdYbYgnKGXzOyxP7qa452HVJN-vneUPAA8QzQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS9xAEB9EQQTR1o82ttY8iG85Lsl-PkrrYf04RBR8W5LdCYhtDOYO1L_enSR39UoLKr7lZbLZ2f3t_iY781uAXeQezbFyERaxilicy0ir1AeuuU24zUhMp1H7HIrDS3Z0xa-68miqhWn1IaY_3AgZzXpNAK9cMQtyQVXRrM-o5E43_zg9_e15RrnAhKcWRJHOp2JSMWnhtWQ4jkQas06CtMvr-c-7Zrar5SqrveeK9sqLf3HSWYrb7FGDVfg96V2bmnLTG4_ynn38S_jxvbr_AVY6Mhvut7PvI8xhuQaLp91x_TrsDagGa3yHIWWwh9d1eF0SS63R-acQK99yVT9swOXg4OL7YdRdzBDZlFQLMM4xlrkSOtWZ1byQicPCsUI4RXoxLJHW4zzT2nEpRaZQKI55obAQGXcu3YT58rbEzxD2pbAydT5OEylz3C8wFp1TLLeYSdtPAtAT_xvbqZbT5Rm_zLPoxTvCkCMMOcJ0jjD3AaRT26rV7niR1fbMMP8xldIvYCKAncmwGw9FOl_JSrwd10b4iJzOQQP41M6GZ61SvTPnAchmTF_xOWZ_eJAIvfVmyx1YPPsxMCc_h8dfYKlVnaB8za8wP7ob47bnVKP8WwOVJ60HD3w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fracture+risk+is+increased+in+epilepsy&rft.jtitle=Acta+neurologica+Scandinavica&rft.au=Vestergaard%2C+P.&rft.au=Tigaran%2C+S.&rft.au=Rejnmark%2C+L.&rft.au=Tigaran%2C+C.&rft.date=1999-05-01&rft.issn=0001-6314&rft.eissn=1600-0404&rft.volume=99&rft.issue=5&rft.spage=269&rft.epage=275&rft_id=info:doi/10.1111%2Fj.1600-0404.1999.tb00675.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1600_0404_1999_tb00675_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-6314&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-6314&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-6314&client=summon